Works with the AI Agents you already use

    Claude CodeClaude CodeCursorCursorCodex CLICodex CLIMuseMuseDotsDots+21 more

    Pharma Deal Signal Monitor

    3

    Identify pre-partnering and M&A opportunities in the pharma industry using real-time press release signal analysis.

    Free

    45 uses5.0 (1 review)
    pharma-deal-signal-monitor

    pharma-deal-signal-monitor

    Example session with this skill installed

    Scan recent pharma news for companies with major clinical milestones, leadership changes, or returned assets that suggest new partnership opportunities.

    • Read your context and instructions
    • Compiled the pharma-deal-signal-monitor

    Pharma BD Deal Signal Report

    ⚡ Compound Signals

    • NexaBio: Ph 3 positive data + New CBO hire (Sarah Jenkins).

    Signal Findings

    • Altus Therapeutics | ALT-102 | NASH | FDA Fast Track (2023-11-20)
    • GeneFlow Inc | GF-9 | Hemophilia | Terminated partnership with BigPharma Co. (2023-11-21)

    Connects securely to your tools. The creator never sees your data.

    About this skill

    High-Level Intelligence for Pharma BD

    The Pharma Deal Signal Monitor is a targeted intelligence tool designed for Business Development (BD) professionals, venture capitalists, and licensing scouts. It solves the "manual monitoring" problem by automatically scanning the latest pharmaceutical press releases for high-intent signals that a company is ready to transact.

    What it does

    This skill performs a multi-vector sweep across the Pharmaceutic Index corpus, analyzing seven distinct categories of deal signals: positive clinical readouts, regulatory milestones, asset reversions, new leadership hires, capital raises, IND filings, and explicit partnering language. It doesn't just surface news; it synthesizes findings into a ranked Deal Signal Report that highlights "Compound Signals"—companies appearing in multiple categories who are most likely to be seeking partners.

    Why use this skill?

    • Go Beyond Keywords: Uses semantic search to find the *concept* of a deal signal rather than just matching text, catching signals human scouts might miss.
    • Identify Early Transitions: Flags termination of prior collaborations and asset reversions, surfacing opportunities before they become public knowledge.
    • Automated BD Pipeline: Turns raw industry news into a curated list of actionable leads categorized by strategic intent.
    • MCP Integration: Connects directly to real-time pharma data via the Pharmaceutic Index MCP server.

    Supported Output

    Each run produces a structured report including company names, specific asset details, indications, development phases, and the key evidentiary passages from the source material, all ranked by signal strength.

    • Covers only recent (7-30 day) press releases.
    • Cannot access historical deal databases.
    • Signal detection may include false positives from general industry news.

    How to use

    1. 1

      Connect your agent to the Agensi MCP

      Copy the prompt and paste it into Claude, ChatGPT, Cursor or any agent that supports MCP. It sets up the connection for you. Manual setup

    2. 2

      Sign in to Agensi

      Your agent shows a sign-in link. Sign in and click Allow.

    3. 3

      Ask for what you need

      Your agent loads this skill and uses it on your task. It always asks before any payment.

    Reviews

    5.0
    1 review
    5
    1
    4
    0
    3
    0
    2
    0
    1
    0

    This skill has been used 45 times.

    Trust & safety

    Security scan

    Security scan passed 4 months ago

    • Free with an Agensi account

    Accounts
    Anthropic
    Software
    Pharmaceutic Index MCP

    Permissions

    Allowed Hosts

    claude.ai

    File Scopes

    Pharma
    Deal
    Signal
    Monitor/**
    __MACOSX/**
    Listed6 months ago
    Updated4 months ago

    What's inside

    Frequently Asked Questions

    This skill solves the problem of manual oversight by automatically scanning pharmaceutical press releases for high-intent 'deal signals,' such as asset reversions or positive clinical data, that indicate a company is ready for a partnership or acquisition.

    No, this skill goes beyond keyword matching by using semantic search to identify the 'concept' of a deal signal, allowing it to catch strategic transitions—like asset reversions or leadership changes—that traditional news alerts often miss.

    Each purchase includes the 'pharma-deal-signal-monitor' skill package, documentation for integration, and full access to data via the Pharmaceutic Index MCP server for real-time intelligence.

    This skill is designed for AI agents that support the Model Context Protocol (MCP), allowing it to connect directly to the Pharmaceutic Index MCP server for live data processing.

    The skill produces a structured 'Deal Signal Report' that includes company names, asset details, development phases, and evidentiary passages from official press releases, all ranked by strategic importance.

    Updates are periodically released to refine the signal analysis engine and add new deal categories; buyers can download the latest version directly from their marketplace library.

    New in Trading & Investing

    Free